FREMGANGSMAADE TIL FREMSTILLING AF FARMACEUTISKE KOMPOSITIONER DER INDEHOLDER TOERT NATRIUM-7-(D-2-FORMYLOXY-2-PHENYLACETAMIDO)-3-(1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLAT

FREMGANGSMAADE TIL FREMSTILLING AF FARMACEUTISKE KOMPOSITIONER DER INDEHOLDER TOERT NATRIUM-7-(D-2-FORMYLOXY-2-PHENYLACETAMIDO)-3-(1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLAT

7-(D-2-Formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazole-5-ylthiom ethyl)-3-cephem-4-carboxylic acid sodium salt, a pure, stable crystalline antibiotic compound, is formulated into parenteral pharmaceutical compositions in dosage unit form and is employed in treating bacterial infections.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JAMES MICHAEL GREENE, JOSEPH MICHAEL INDELICATO
Format: Patent
Sprache:dan
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:7-(D-2-Formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazole-5-ylthiom ethyl)-3-cephem-4-carboxylic acid sodium salt, a pure, stable crystalline antibiotic compound, is formulated into parenteral pharmaceutical compositions in dosage unit form and is employed in treating bacterial infections.